GlycoMimetics (NASDAQ: GLYC) reported Q4 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.